Online GLP-1 Programs in Ohio

Insurance

Does Ohio Medicaid cover GLP-1s?

Ohio Medicaid does not cover GLP-1s for adult weight loss (a narrow pediatric childhood-obesity exception exists). The decision is tied to cost: Medicaid GLP-1 spending rose from about $172 million in 2021 to roughly $431 million, with recipients climbing to about 75,000 (ABC6, 2025). The state also eliminated weight-loss GLP-1 coverage for its own employees effective July 2025. GLP-1s for type 2 diabetes are covered, as federal law requires.

Online Access

Getting a GLP-1 online in Ohio

GLP-1s are not controlled substances, so Ohio allows them to be prescribed via telehealth. Under the State Medical Board's rules (OAC 4731-37-01), a clinician may prescribe a non-controlled drug to a patient they have never examined in person, as long as identity, location, consent, and a valid telehealth relationship are established (Ohio Administrative Code). The prescriber must be Ohio-licensed.

Compounding

Compounded semaglutide & tirzepatide in Ohio

Routine compounding of semaglutide and tirzepatide ended after the FDA resolved the shortages in early 2025 (FDA, 2025). Ohio adds no special carve-out beyond the federal 503A/503B framework, so compounding is limited to documented, patient-specific clinical need.

Demand

Where GLP-1 demand is highest in Ohio

Nearly 37% of Ohio adults have obesity and about 13% have diagnosed diabetes (CDC BRFSS via America's Health Rankings, 2024), among the higher burdens nationally. Demand spreads across the three big metros, Columbus, Cleveland, and Cincinnati. The spending surge that prompted Ohio to hold the line on coverage signals just how strong that demand has become.

Questions

Ohio GLP-1 FAQ

Compound Guides

The GLP-1s behind these programs

Sources

How we sourced this page

Coverage, prevalence, and policy figures are drawn from primary and authoritative sources, last reviewed June 2026.